| Osafo Health Care Clinic Inc | |
|
303 Quadrangle Dr Bolingbrook IL 60440-3409 | |
| (630) 771-1070 | |
| (630) 771-1030 |
| Full Name | Osafo Health Care Clinic Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 303 Quadrangle Dr, Bolingbrook, Illinois |
| Authorized Official Name and Position | Seth K Osafo (PRESIDENT) |
| Authorized Official Contact | 3096903369 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Osafo Health Care Clinic Inc 1107 W Cayman Cv Peoria IL 61615-4301 Ph: (309) 690-3369 | Osafo Health Care Clinic Inc 303 Quadrangle Dr Bolingbrook IL 60440-3409 Ph: (630) 771-1070 |
| NPI Number | 1114106978 |
|---|---|
| Provider Enumeration Date | 10/29/2007 |
| Last Update Date | 10/29/2007 |
| Medicare PECOS PAC ID | 5799863155 |
|---|---|
| Medicare Enrollment ID | O20080425000026 |
News Archive
The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Masimo announced today that a new clinical study demonstrating the clinical accuracy of its noninvasive and continuous hemoglobin (SpHb®) monitoring technology breakthrough was presented last week at the Society for Technology in Anesthesia (STA) Annual Meeting.
Pregnant women should avoid taking vitamin D supplements. Substitution appears to raise the risk of children developing a food allergy after birth.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114106978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | (Illinois) | Primary |
| Provider Name | Seth K Osafo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841330537 PECOS PAC ID: 1355240482 Enrollment ID: I20040107000636 |
News Archive
The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Masimo announced today that a new clinical study demonstrating the clinical accuracy of its noninvasive and continuous hemoglobin (SpHb®) monitoring technology breakthrough was presented last week at the Society for Technology in Anesthesia (STA) Annual Meeting.
Pregnant women should avoid taking vitamin D supplements. Substitution appears to raise the risk of children developing a food allergy after birth.
› Verified 8 days ago
| Provider Name | Nkone Adu Antwi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720680606 PECOS PAC ID: 4082002407 Enrollment ID: I20211103002314 |
News Archive
The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Masimo announced today that a new clinical study demonstrating the clinical accuracy of its noninvasive and continuous hemoglobin (SpHb®) monitoring technology breakthrough was presented last week at the Society for Technology in Anesthesia (STA) Annual Meeting.
Pregnant women should avoid taking vitamin D supplements. Substitution appears to raise the risk of children developing a food allergy after birth.
› Verified 8 days ago
News Archive
The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Masimo announced today that a new clinical study demonstrating the clinical accuracy of its noninvasive and continuous hemoglobin (SpHb®) monitoring technology breakthrough was presented last week at the Society for Technology in Anesthesia (STA) Annual Meeting.
Pregnant women should avoid taking vitamin D supplements. Substitution appears to raise the risk of children developing a food allergy after birth.
› Verified 8 days ago
Boling Medical Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 899 S Weber Rd, Suite G, Bolingbrook, IL 60490 Phone: 630-226-1800 Fax: 630-226-4226 | |
Associates Of Inpatient Management Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1000 Remington Blvd, Ste 200, Bolingbrook, IL 60440 Phone: 630-312-7865 | |
Bolingbrook Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 329 Remington Blvd, Ste 100, Bolingbrook, IL 60440 Phone: 630-759-4800 Fax: 630-759-6927 | |
Sabs Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 899 S Weber Rd, Suite A, Bolingbrook, IL 60490 Phone: 630-544-7283 Fax: 708-221-6631 | |
Premier Occupational Health Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 550 E Boughton Rd, # 140, Bolingbrook, IL 60440 Phone: 630-972-0733 | |
Presence Healthcare Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1000 Remington Blvd Ste 100, Bolingbrook, IL 60440 Phone: 630-914-2468 | |
Medical Home Care Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 167 W Boughton Rd Ste C, Bolingbrook, IL 60440 Phone: 331-871-6674 |